Santa Cruz Biotechnology offers a broad range of KLHL2 monoclonal antibodies for investigating KLHL2 protein function. KLHL2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KLHL2, a member of the Kelch-like protein family, plays a critical role in cellular processes such as protein degradation and signal transduction. KLHL2 influences cell cycle progression and apoptosis through various biological pathways. Research has shown KLHL2's significance in cancer development and neurodegenerative disorders. KLHL2 monoclonal antibodies enable precise detection and analysis of KLHL2 expression patterns across different cell types and tissues. Studying KLHL2 localization and interactions provides valuable insights into cellular regulation mechanisms. Understanding KLHL2's molecular functions helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of cellular processes and disease mechanisms.